Evidence map›Paper›PMID 30514861›Full record

ArticleScientific reports2018

Epistatic Interaction of ERAP1 and HLA-B*51 in Iranian Patients with Behçet's Disease.

Mahdi Mahmoudi, Amir Ashraf-Ganjouei, Ali Javinani, Farhad Shahram, Akira Meguro, Nobuhisa Mizuki, Nooshin Ahmadzadeh, Saeideh Jafarinejad-Farsangi, Shayan Mostafaei, Hoda Kavosi and 3 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
0.6field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 11 citations in OpenAlex.

  1. Pooled it
  2. Exploring the Involvement ofLife (Basel, Switzerland) · 2026
    Review
  3. Article
  4. Review
  5. Genetics in Behcet's Disease: An Update Review.Frontiers in ophthalmology · 2022
    Review
  6. The Immunogenetics of Behcet's Disease.Advances in experimental medicine and biology · 2022
    Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 2 countries.

Mahdi MahmoudiRheumatology Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Amir Ashraf-GanjoueiRheumatology Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Ali JavinaniRheumatology Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Farhad ShahramRheumatology Research Center, Tehran University of Medical Sciences, Tehran, Iran.ORCID http://orcid.org/0000-0003-1830-6203
Akira MeguroDepartment of Ophthalmology and Visual Science, Yokohama City University Graduate School of Medicine, Yokohama, Japan. akmeguro@yokohama-cu.ac.jp.ORCID http://orcid.org/0000-0002-9797-0948
Nobuhisa MizukiDepartment of Ophthalmology and Visual Science, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Nooshin AhmadzadehRheumatology Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Saeideh Jafarinejad-FarsangiRheumatology Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Shayan MostafaeiRheumatology Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Hoda KavosiRheumatology Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Seyedeh Tahereh FaeziRheumatology Research Center, Tehran University of Medical Sciences, Tehran, Iran. tfaezi@sina.tums.ac.ir.
Maassoumeh AkhlaghiRheumatology Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Fereydoun DavatchiRheumatology Research Center, Tehran University of Medical Sciences, Tehran, Iran.ORCID http://orcid.org/0000-0003-0508-7013
Tehran University of Medical Sciences · IRYokohama City University · JPKermanshah University of Medical Sciences · IRKerman University of Medical Sciences · IRSina Hospital · IR

Funding

Tehran University of Medical Sciences and Health Services (TUMS) 91-04-41-19380
6 · The paper itself

Abstract

Behçet's Disease (BD) pathogenesis remains unclear, but some genetic loci and environmental factors are proposed to play a role. Here, we investigate the association of the endoplasmic reticulum aminopeptidase-1 (ERAP1) gene variants and HLA-B*51 with BD susceptibility and clinical manifestations in Iranian patients. In the study, 748 BD patients and 776 healthy individuals were included. The MGB-TaqMan Allelic Discrimination method was used to genotype 10 common missense single nucleotide polymorphisms (SNPs) and one intronic SNP in the ERAP1 gene region. We found no significant association between the 11 SNPs and BD in allelic and genotypic association tests. However, rs30187 showed the strongest association with BD in the recessive genotype model of the risk T allele in HLA-B*51 carriers. Although this became insignificant after correcting for multiple comparisons, the homozygous rs30187 risk allele genotype (TT) increased disease susceptibility in HLA-B*51 carriers in epistasis analysis, and the rs30187 TT recessive genotype showed a significant association with risk of cardiac involvement in the all patients and articular involvements in HLA-B*51 positive patients. Our findings suggest that gene-gene interactions between HLA-B*51 and ERAP1 variants is important for BD development, however, ERAP1 variants which interact with HLA-B*51 may differ among disease phenotypes or populations.

Indexed as

Epistasis, GeneticGenetic Predisposition to DiseaseAdolescentAdultAgedAminopeptidasesBehcet SyndromeChildChild, PreschoolFemaleHLA-B27 AntigenHumansInfantInfant, NewbornIranMaleAminopeptidasesERAP1 protein, humanHLA-B27 AntigenHLA-B protein, humanMinor Histocompatibility Antigens

Identifiers

PMID30514861
PMCPMC6279803
OpenAlexW2903251821

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.